97384738 - CREATING TIME

Information

• Trademark
• 97384738

• Source

• Serial Number

  97384738

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  April 27, 2022
  2 years ago

• Transaction Date

  February 16, 2024
  4 months ago

• Status Date

  February 15, 2024
  4 months ago

• Published for Opposition Date

  June 20, 2023
  a year ago

• Location Date

  August 15, 2023
  10 months ago

• Status Code

  730

• Current Location

  INTENT TO USE SECTION

  Employee Name

  REID, MONICA R

• Attorney Docket Number

  5046.0030000

  Attorney Name

  Tracy-Gene G. Durkin

  Law Office Assigned Location Code

  N80

• Owners

  • Gordian Biotechnology, Inc.

Case File Statements

• GS0051: Pharmaceutical preparations, biological preparations, and cell- and gene-based therapy products to prevent and treat age-related cardiovascular disease, neurodegenerative disease, musculoskeletal disease, pulmonary disease, metabolic disease, diseases of the liver, macular degeneration and other ocular diseases, kidney disease, and cancer; pharmaceutical preparations, biological preparations, and cell- and gene-based therapy products to prevent and treat age-related cardiovascular disease, neurodegenerative disease, musculoskeletal disease, pulmonary disease, metabolic disease, diseases of the liver, macular degeneration and other ocular diseases, kidney disease, and cancer
• GS0441: Providing medical information on aging and complex multigenic diseases
• GS0421: Pharmaceutical and biological drug research and development services; research and development of pharmaceutical and biotechnology fields, namely, cell- and gene-based therapy research and development services; providing information about medical and scientific research on aging and complex multigenic diseases; providing information about medical and scientific research, namely, providing information on pharmaceutical drug, biological drug, and cell- and gene-based therapy research and development; providing scientific information on computational biology, machine learning, and bioinformatics

Case File Event Statements

• 2/16/2024 - 4 months ago

  18 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 2/15/2024 - 4 months ago

  17 - SOU EXTENSION 1 GRANTED Type: EX1G

• 2/15/2024 - 4 months ago

  16 - SOU EXTENSION 1 FILED Type: EXT1

• 2/15/2024 - 4 months ago

  15 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 8/15/2023 - 10 months ago

  14 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 6/20/2023 - a year ago

  13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 6/20/2023 - a year ago

  12 - PUBLISHED FOR OPPOSITION Type: PUBO

• 5/31/2023 - a year ago

  11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 5/15/2023 - a year ago

  10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 5/11/2023 - a year ago

  9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 5/10/2023 - a year ago

  8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 5/10/2023 - a year ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 2/15/2023 - a year ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 2/15/2023 - a year ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 2/15/2023 - a year ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 2/14/2023 - a year ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 5/3/2022 - 2 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 4/30/2022 - 2 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP